Novartis (Farm Animal)
Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid
For Use In Animals Only
INDICATIONS: For use in healthy pregnant cattle as an aid in the prevention of enterotoxemia in calves caused by Clostridium perfringens Type C and colibacillosis in calves caused by K99 piliated Escherichia coli.
ADJUVANT: Xtend® III
DIRECTIONS: Shake well before using. Administer 1 mL intramuscularly in the neck 8-16 weeks prior to calving. Vaccinate dairy cows at dry off. Revaccinate prior to each subsequent calving.
PRECAUTIONS: Store out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. It is essential that newborn calves receive colostrum from the vaccinated dam. WARNING: THIS PRODUCT MAY CAUSE PERSISTENT SWELLING AT THE SITE OF INJECTION. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains thimerosal as a preservative.
U.S. Vet. License No. 303; Novartis Animal Health US, Inc., Larchwood, IA 51241 USA; ©2004 Novartis Animal Health US, Inc., All rights reserved; Pili Shield is a trademark of Novartis AG; Xtend is a registered trademark of Novartis AG